Valo Health

Company profile

About Valo Health

Valo Health is redefining drug discovery by integrating AI-enabled human causal biology with closed-loop chemistry to accelerate therapeutic development. The company harnesses artificial intelligence and machine learning to find patterns in large-scale human data, identify novel disease targets, and rapidly engineer novel small molecules. At the heart of Valo's approach is deep integration across disciplines including biology, chemistry, and engineering, creating an interconnected R&D engine designed to turn patient insights into new medicines. Valo's Human Causal Biology platform uses AI/ML, advanced causal inference techniques, and statistical genetics to uncover causal relationships in large-scale human data, identify targets for therapeutic intervention, and validate them in human tissue. Their Closed-Loop Chemistry capabilities allow them to explore vast chemical spaces and identify novel, diverse lead compounds quickly, with models rapidly refined after each round of experiments. The company operates through a dual approach: advancing its own pipeline of assets while partnering with pharmaceutical companies to accelerate pre-clinical R&D. Valo collaborates with aligned incentives, advancing early-stage R&D to spark innovation while partners lead clinical development. The company retains royalties and uses success-based economics to foster shared risk and reward collaborations. Valo serves pharmaceutical companies, research institutions, and aims to deliver transformative therapies to patients through a networked model of innovation.

Company description · Valo Health official website

Mission. Our mission is to transform drug discovery through AI-enabled human causal biology and predictive chemistry.